Malcolm Finlayson
Venture Partner

Dr. Malcolm Finlayson served as Entrepreneur in Residence in Hamilton I, helping to find and evaluate the fundís investment in Egea Biosciences. Dr. Finlayson served as President of Egea from 2001 through the successful sale in 2004 to Johnson & Johnson. Formerly, Dr. Finlayson was Director of R&D, COO, then President of a Division of Invitrogen Corporation, San Diegoís largest Biotechnology company. Dr. Finlayson has also been a management consultant to Biotechnology companies, and a research scientist at the Scripps Research Institute in La Jolla, California. Dr. Finlayson has authored numerous publications.

Dr. Finlayson received a Ph.D. in Pharmacology and Toxicology from the University of British Columbia, and a B.A. in Molecular Biology from San Jose State University.

Our Team
Investment Parameters
Contact Form
Management & Investment Team
Robert F. Ellsworth
Past Chairman & Founding Director

Richard J. Crosby
Managing Director

Donald W. Grimm

Dr. Kerry Dance
Managing Director

Malcolm Finlayson
Venture Partner

Elliot Parks

Administration Team
Ellen Smock
Administrative Manager

Ann Collins

Anita Minard
Administrative Support

Malcolm Nita Donald W. Grimm Ann Collins Dr. Kerry Dance Elliot Robert F. Ellsworth Richard J. Crosby Larry Ellen Shmock